http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111035754-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9de45a91ab50edb37b5f7905ce99f91 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
filingDate | 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18ba96944916e6f9cb8e7c5813dcdf65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f92d4ddb095fbba9b385b48c834a7997 |
publicationDate | 2020-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111035754-A |
titleOfInvention | Application of antiplatelet thrombolytics in the preparation of drugs for the treatment of thrombotic thrombocytopenic purpura |
abstract | The invention relates to the field of medicine, in particular to the application of an antiplatelet thrombolytic agent in the preparation of a medicine for treating thrombotic thrombocytopenic purpura (Thrombotic Thrombocytopenic Purpura, TTP). The anti-platelet thrombolytic agent of the invention limits the adhesion and aggregation of platelets, restores the levels of platelets, red blood cells and hemoglobin, reduces the level of lactate dehydrogenase, and effectively inhibits thrombocytopenia and schistocytic hemolytic anemia, thereby achieving the treatment of TTP It has a good clinical application prospect. |
priorityDate | 2016-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 223.